000 | 01365 a2200337 4500 | ||
---|---|---|---|
005 | 20250515124215.0 | ||
264 | 0 | _c20080812 | |
008 | 200808s 0 0 eng d | ||
022 | _a1747-597X | ||
024 | 7 |
_a10.1186/1747-597X-3-17 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDucharme, Lori J | |
245 | 0 | 0 |
_aState policy influence on the early diffusion of buprenorphine in community treatment programs. _h[electronic resource] |
260 |
_bSubstance abuse treatment, prevention, and policy _cJun 2008 |
||
300 |
_a17 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aBuprenorphine _xadministration & dosage |
650 | 0 | 4 |
_aCommunity Health Services _xorganization & administration |
650 | 0 | 4 | _aDiffusion of Innovation |
650 | 0 | 4 | _aFormularies as Topic |
650 | 0 | 4 | _aHealth Policy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMedicaid _xorganization & administration |
650 | 0 | 4 |
_aNarcotic Antagonists _xadministration & dosage |
650 | 0 | 4 |
_aOpioid-Related Disorders _xdrug therapy |
650 | 0 | 4 | _aState Government |
650 | 0 | 4 | _aUnited States |
700 | 1 | _aAbraham, Amanda J | |
773 | 0 |
_tSubstance abuse treatment, prevention, and policy _gvol. 3 _gp. 17 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1186/1747-597X-3-17 _zAvailable from publisher's website |
999 |
_c18054841 _d18054841 |